Andrea Flynn | VP & Head, IR |
Bruce Cozadd | Co-Founder, Chairman & CEO |
Daniel Swisher | President |
Robert Iannone | EVP, Research & Development & Chief Medical Officer |
Renee Gala | EVP & CFO |
Kim Sablich | EVP & GM, North America |
Marc Goodman | SVB Leerink |
Jason Gerberry | Bank of America Merrill Lynch |
Jessica Fye | JPMorgan Chase & Co. |
Jeff Hung | Morgan Stanley |
Ami Fadia | Needham & Company |
Gary Nachman | BMO Capital Markets |
Akash Tewari | Jefferies |
Balaji Prasad | Barclays Bank |
Esther Rajavelu | UBS |
Aaron Gal | Sanford C. Bernstein & Co. |
Brandon Folkes | Cantor Fitzgerald & Co. |
David Amsellem | Piper Sandler & Co. |
Kenneth Cacciatore | Cowen and Company |
Gregory Fraser | Truist Securities |
Navann Ty | Citigroup |
Good afternoon, ladies and gentlemen, and welcome to the Third Quarter 2021 Jazz Pharmaceuticals Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to your host, Ms. Andrea Flynn, Head of Investor Relations. Ma'am, please go ahead.